Erasca
The Sr Manager or Associate Director, Regulatory Operations leads regulatory operations across the company's portfolio, building and managing the Regulatory Information Management System and overseeing submission planning and execution. This role establishes efficient processes for regulatory records, document management, and health authority correspondence while collaborating with cross-functional teams to ensure timely, high-quality regulatory submissions. The position reports to the Chief Regulatory Affairs Officer and can be hybrid in San Diego or South San Francisco, or fully remote within the United States.
Headquarters
San Diego, California, United States
Company Size
51-200 employees
Founded
2018
Erasca is a clinical-stage precision oncology company on a mission “to erase cancer,” focused on therapies that shut down the RAS/MAPK signaling cascade — one of the most commonly mutated cancer pathways. Its pipeline comprises targeted programs that attack the RAS/MAPK pathway at multiple nodes, with the goal of addressing cancers driven by these mutations (a pathway that affects roughly 5.5 million people worldwide each year). By developing precision small molecules and combination strategies, Erasca aims to deliver transformative treatments that improve outcomes across a broad range of devastating cancers.
Analysts Offer Insights on Healthcare Companies: BeOne Medicines (ONC), Argenx Se (ARGX) and Erasca (ERAS)
1 day ago
RAS buzz lifts Erasca | ApexOnco - Clinical Trials news and analysis
Jan 14, 2026
Erasca (NASDAQ: ERAS) narrows 2025 loss and funds runway into H2 2028
5 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Erasca.
Erasca secures worldwide rights to RAS-targeting drug ERAS-0015 By Investing.com
3 days ago
Principal Regulatory Affairs Specialist
Crazy Compression
Senior Vice President, Regulatory Affairs
Vir Biotechnology
Director Molecular Regulatory Affairs, North America
Your domain is suspended
Regulatory Affairs Associate
AstraZeneca
Assoc Regulatory Affairs CMC Director
Exelixis
Senior Director of Regulatory Affairs
ardelyx